3 ms·
It should be a joke for a generic drug company to take generic S-Ketamine and put it in another insufflation device and show bio equivalency. You don’t patent
by Scoundreller 8y ago
It should be a joke for a generic drug company to take generic S-Ketamine and put it in another insufflation device and show bio equivalency.
You don’t patent indications.
- Symmetry 8y agoI don't think it's a joke that they could patent their special version of ketamine, I think it's a joke that despite the fact that we've been using ketatmine for generations and despite the fact that it's anti-depressant qualities are well attested to in the literature this brand of s-ketamine is the only one doctors are allowed to use. And there's research[1] showing that most of racemic ketamine's effect is from the r-ketamine, not the s-ketamine. [1]https://www.sciencedirect.com/science/article/pii/S0091305713003328?via%3Dihub https://www.sciencedirect.com/science/article/pii/S009130571...
- Scoundreller 8y agoThere’s no way they were the first to synthesize the S énantiomor. Usually doctors can still prescribe the compounded forms as long as they’re not duplicating something commercially available.
- refurb 8y agoYou don’t patent them, but you do get exclusivity with the FDA approval. FDA won’t approve another drug for 3-7 years.